238 related articles for article (PubMed ID: 33650667)
1. DDX41 regulates the expression and alternative splicing of genes involved in tumorigenesis and immune response.
Qin K; Jian D; Xue Y; Cheng Y; Zhang P; Wei Y; Zhang J; Xiong H; Zhang Y; Yuan X
Oncol Rep; 2021 Mar; 45(3):1213-1225. PubMed ID: 33650667
[TBL] [Abstract][Full Text] [Related]
2. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
[TBL] [Abstract][Full Text] [Related]
3. ATP5A1 Participates in Transcriptional and Posttranscriptional Regulation of Cancer-Associated Genes by Modulating Their Expression and Alternative Splicing Profiles in HeLa Cells.
Song Ba Y; Wang Ma F; Wei Ma Y; Chen Ba D; Deng Ba G
Technol Cancer Res Treat; 2021; 20():15330338211039126. PubMed ID: 34520292
[No Abstract] [Full Text] [Related]
4. Filamin B extensively regulates transcription and alternative splicing, and is associated with apoptosis in HeLa cells.
Ma HR; Cao L; Wang F; Cheng C; Jiang R; Zhou H; Xie Z; Wuermanbieke S; Qian Z
Oncol Rep; 2020 May; 43(5):1536-1546. PubMed ID: 32323860
[TBL] [Abstract][Full Text] [Related]
5. Identification of spliceosome components pivotal to breast cancer survival.
An J; Luo Z; An W; Cao D; Ma J; Liu Z
RNA Biol; 2021 Jun; 18(6):833-842. PubMed ID: 32965163
[TBL] [Abstract][Full Text] [Related]
6. Spliceosomal helicases DDX41/SACY-1 and PRP22/MOG-5 both contribute to proofreading against proximal 3' splice site usage.
Osterhoudt K; Bagno O; Katzman S; Zahler AM
RNA; 2024 Mar; 30(4):404-417. PubMed ID: 38282418
[TBL] [Abstract][Full Text] [Related]
7. SERBP1 affects the apoptotic level by regulating the expression and alternative splicing of cellular and metabolic process genes in HeLa cells.
Zhou J; Chen W; He Q; Chen D; Li C; Jiang C; Ding Z; Qian Q
PeerJ; 2022; 10():e14084. PubMed ID: 36213507
[TBL] [Abstract][Full Text] [Related]
8. The DEAD-box RNA helicase DDX41 is a novel repressor of p21
Peters D; Radine C; Reese A; Budach W; Sohn D; Jänicke RU
J Biol Chem; 2017 May; 292(20):8331-8341. PubMed ID: 28348086
[TBL] [Abstract][Full Text] [Related]
9. QKI-Regulated Alternative Splicing Events in Cervical Cancer: Pivotal Mechanism and Potential Therapeutic Strategy.
Luo Y; Li Y; Ge P; Zhang K; Liu H; Jiang N
DNA Cell Biol; 2021 Oct; 40(10):1261-1277. PubMed ID: 34551268
[TBL] [Abstract][Full Text] [Related]
10. Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5.
Che Y; Bai M; Lu K; Fu L
Mol Carcinog; 2023 Feb; 62(2):210-223. PubMed ID: 36282044
[TBL] [Abstract][Full Text] [Related]
11. DEAD-box helicase 56 functions as an oncogene promote cell proliferation and invasion in gastric cancer via the FOXO1/p21 Cip1/c-Myc signaling pathway.
Wang J; Wang Y; Wang J; Zhang S; Yu Z; Zheng K; Fu Z; Wang C; Huang W; Chen J
Bioengineered; 2022 May; 13(5):13970-13985. PubMed ID: 35723050
[TBL] [Abstract][Full Text] [Related]
12. DDX41: exploring the roles of a versatile helicase.
Winstone L; Jung Y; Wu Y
Biochem Soc Trans; 2024 Feb; 52(1):395-405. PubMed ID: 38348889
[TBL] [Abstract][Full Text] [Related]
13. Ddx41 inhibition of DNA damage signaling permits erythroid progenitor expansion in zebrafish.
Weinreb JT; Gupta V; Sharvit E; Weil R; Bowman TV
Haematologica; 2022 Mar; 107(3):644-654. PubMed ID: 33763998
[TBL] [Abstract][Full Text] [Related]
14. Myeloid neoplasms with germline DDX41 mutation.
Cheah JJC; Hahn CN; Hiwase DK; Scott HS; Brown AL
Int J Hematol; 2017 Aug; 106(2):163-174. PubMed ID: 28547672
[TBL] [Abstract][Full Text] [Related]
15. DDX41 is needed for pre- and postnatal hematopoietic stem cell differentiation in mice.
Ma J; Mahmud N; Bosland MC; Ross SR
Stem Cell Reports; 2022 Apr; 17(4):879-893. PubMed ID: 35303436
[TBL] [Abstract][Full Text] [Related]
16. Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms.
Polprasert C; Schulze I; Sekeres MA; Makishima H; Przychodzen B; Hosono N; Singh J; Padgett RA; Gu X; Phillips JG; Clemente M; Parker Y; Lindner D; Dienes B; Jankowsky E; Saunthararajah Y; Du Y; Oakley K; Nguyen N; Mukherjee S; Pabst C; Godley LA; Churpek JE; Pollyea DA; Krug U; Berdel WE; Klein HU; Dugas M; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Yoshida K; Ogawa S; Müller-Tidow C; Maciejewski JP
Cancer Cell; 2015 May; 27(5):658-70. PubMed ID: 25920683
[TBL] [Abstract][Full Text] [Related]
17. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
18. SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-κB-CD47 axis.
Liu F; Dai M; Xu Q; Zhu X; Zhou Y; Jiang S; Wang Y; Ai Z; Ma L; Zhang Y; Hu L; Yang Q; Li J; Zhao S; Zhang Z; Teng Y
Oncogene; 2018 May; 37(18):2394-2409. PubMed ID: 29429992
[TBL] [Abstract][Full Text] [Related]
19. Tristetraprolin specifically regulates the expression and alternative splicing of immune response genes in HeLa cells.
Tu Y; Wu X; Yu F; Dang J; Wang J; Wei Y; Cai Z; Zhou Z; Liao W; Li L; Zhang Y
BMC Immunol; 2019 May; 20(1):13. PubMed ID: 31046669
[TBL] [Abstract][Full Text] [Related]
20. RBM4 modulates the proliferation and expression of inflammatory factors via the alternative splicing of regulatory factors in HeLa cells.
Wang WY; Quan W; Yang F; Wei YX; Chen JJ; Yu H; Xie J; Zhang Y; Li ZF
Mol Genet Genomics; 2020 Jan; 295(1):95-106. PubMed ID: 31489484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
